10.1002/ejoc.201701760
European Journal of Organic Chemistry
FULL PAPER
General procedure for the Rh-mediated asymmetric hydrogenation
of functionalized substrates: A solution of the required amount of
[Rh(nbd)2]BF4 (1.0 mol-%) and POP ligand L8 L9 (1.1 mol-%) and the
corresponding functionalized olefin (0.10 mmol) in anhydrous and
degassed tetrahydrofuran (0.50 mL) was prepared inside a glass vessel
under N2 atmosphere working in a glove box. In all cases, the molar
concentration of a given substrate in the reaction medium was adjusted
to 0.20 M. Once the reaction mixture had been loaded, the glass vessel
was then placed into one of the positions of a steel autoclave reactor
(HEL Cat-24 parallel pressure multireactor). The autoclave was purged
three times with H2 gas (at a pressure not higher than the selected one)
and finally, the autoclave was pressurized under the required pressure of
H2 gas. The reaction mixture was stirred at r.t. for 18 h (overnight
reaction). The autoclave was then slowly depressurized. The reaction
mixture was filtered through a short pad of SiO2 and eluted with ethyl
acetate (1.0 mL). The resulting solution was concentrated under vacuum
and the conversion was determined by 1H NMR. The enantiomeric
excess was determined by GC or HPLC analysis on chiral stationary
phases.
I. J. Munslow, J. Benet-Buchholz, F. Maseras, A. Vidal-Ferran, Chem.
Eur. J. 2010, 16, 6495-6508; c) H. Fernández-Pérez, P. Etayo, J. L.
Núñez-Rico, A. Vidal-Ferran, Chim. Oggi 2010, 28, XXVI-XXVIII; d) J. L.
Núñez-Rico, P. Etayo, H. Fernández-Pérez, A. Vidal-Ferran, Adv.
Synth. Catal. 2012, 354, 3025-3035.
[6]
[7]
P. Etayo, J. L. Núñez-Rico, H. Fernández-Pérez, A. Vidal-Ferran,
Chem. Eur. J. 2011, 17, 13978-13982.
The change to the (S)-configuration in the hydrogenation products of
itaconic acid derivatives and analogues is due to an inversion in the
CIP priority rules.
[8]
[9]
a) H. Fernandez-Perez, J. Benet-Buchholz, A. Vidal-Ferran, Org. Lett.
2013, 15, 3634-3637; b) H. Fernandez-Perez, J. Benet-Buchholz, A.
Vidal-Ferran, Chem. Eur. J. 2014, 20, 15375-15384; c) J. R. Lao, J.
Benet-Buchholz, A. Vidal-Ferran, Organometallics 2014, 33, 2960-
2963.
For the synthesis and characterization data of ligands L8 and L9, see: J.
R. Lao, H. Fernández-Pérez, A. Vidal-Ferran, Org. Lett. 2015, 17,
4114-4117.
[10] B. Balakrishna, A. Bauzá, A. Frontera, A. Vidal-Ferran, Chem. Eur. J.
2016, 22, 10607-10613.
Supporting Information (see footnote on the first page of this article): X-
ray crystal structures (CCDC 1589126-1589127), 1H, 13C, and 31P NMR
spectra of all new compounds, chiral GC and HPLC analyses of the
catalytic reactions.
[11] For the experimental preparation and characterization data, see the
following reference: B. Balakrishna, A. Vidal-Ferran, Synthesis 2016, 48,
997-1001.
[12] Partially hydrogenated binaphthyl motifs in ligands L8 and L9 present
larger dihedral angles between the two aryl rings than those containing
naphthyl fragments. This geometrical parameter usually translates into
higher occupation volumes. For a general review on this topic, see the
following reference: T. T.-L. Au-Yeng, S.-S. Chan, A. S. C. Chan, Adv.
Synth. Catal. 2003, 345, 537-555.
Acknowledgements
We thank MINECO (CTQ2014-60256-P and Severo Ochoa
Excellence Accreditation SEV-2013-0319), the ICIQ Foundation
for financial support, and Dr. J. Benet-Buchholz for X-ray
crystallographic analysis. B. Balakrishna thanks the AGAUR for
a pre-doctoral fellowship (2013FI-B 00545). We are grateful to
[13] The synthesis and characterization data of ligand L10 have been
reported in the reference [10].
[14] Using a rhodium catalyst derived from Me-PennPhos ligand, see: a) Z.
Zhang, G. Zhu, Q. Jiang, D. Xiao, X. Zhang, J. Org. Chem. 1999, 64,
1774-1775; or using a rhodium catalyst derived from Phthalaphos
ligand, see: b) L. Pignataro, M. Boghi, M. Civera, S. Carboni, U. Piarulli,
C. Gennari, Chem. Eur. J. 2012, 18, 1383-1400.
Keywords: Asymmetric catalysis • Hydrogenation • Rhodium •
[15] Using
a rhodium catalyst derived from triphosphorous bidentate
phosphine–phosphoramidite ligand, see: a) W. Zhang, X. Zhang,
Angew. Chem., Int. Ed. 2006, 45, 5515-5518; or using a rhodium
catalyst derived from DioxyBenzP* ligand, see: b) T. Imamoto, K.
Tamura, Z. Zhang, Y. Horiuchi, M. Sugiya, K. Yoshida, A. Yanagisawa,
I. D. Gridnev, J. Am. Chem. Soc. 2012, 134, 1754-1769.
Bidentate ligands • P ligands
[16] G. B. Shinde, N. C. Niphade, S. P. Deshmukh, R. B. Toche, V. T.
Mathad, Org. Process Res. Dev. 2011, 15, 455-461, and references
cited therein for recent synthetic approaches towards cinacalcet.
[17] a) T. Wang, S. Ioannidis, L. Almeida, M. H. Block, A. M. Davies, M. L.
Lamb, D. A. Scott, M. Su, H.-J. Zhang, M. Alimzhanov, G. Bebernitz, K.
Bell, M. Zinda, Bioorg. Med. Chem. Lett. 2011, 21, 2958-2961; b) S.
Ioannidis, M. L. Lamb, T. Wang, L. Almeida, M. H. Block, A. M. Davies,
B. Peng, M. Su, H.-J. Zhang, E. Hoffmann, C. Rivard, I. Green, T.
Howard, H. Pollard, J. Read, M. Alimzhanov, G. Bebernitz, K. Bell, M.-
W. Ye, D. Huszar, M. Zinda, J. Med. Chem. 2011, 54, 262-276; c) M. B.
Sonbol, B. Firwana, A. Zarzour, M. Morad, V. Rana, R. V. Tiu, Ther.
Adv. Hematol. 2013, 4, 15-35.
[1]
[2]
For general reviews, see: a) H. Fernández-Pérez, P. Etayo, A.
Panossian, A. Vidal-Ferran, Chem. Rev. 2011, 111, 2119-2176; b) J.
Wassenaar, J. N. H. Reek, Org. Biomol. Chem. 2011, 9, 1704-1713; c)
A. Pizzano, Chem. Rec. 2016, 16, 2595-2618.
a) N. Sakai, S. Mano, K. Nozaki, H. Takaya, J. Am. Chem. Soc. 1993,
115, 7033-7034; b) K. Nozaki, H. Takaya, T. Hiyama, Top. Catal. 1997,
4, 175-185.
[3]
[4]
O. Pàmies, M. Diéguez, G. Net, A. Ruiz, C. Claver, Chem. Commun.
2000, 2383-2384.
For ligand L3, see the reference: a) S. Deerenberg, O. Pàmies, M.
Diéguez, C. Claver, P. C. J. Kamer, P. W. N. M. van Leeuwen, J. Org.
Chem. 2001, 66, 7626-7631; for ligand L4, see the reference: b) A.
Suárez, A. Pizzano, Tetrahedron: Asymmetry 2001, 12, 2501-2504; for
ligand L5, see the reference: c) Y. Yan, Y. Chi, X. Zhang, Tetrahedron:
Asymmetry 2004, 15, 2173-2175.
[18] X. Wang, A. Guram, S. Caille, J. Hu, J. P. Preston, M. Ronk, S. Walker,
Org. Lett. 2011, 13, 1881-1883.
[19] a) M. J. Burk, G. Casy, N. B. Johnson, J. Org. Chem. 1998, 63,
6084−6085; b) B. Mohar, M. Stephan, Adv. Synth. Catal. 2013, 355,
594-600.
[5]
a) H. Fernández-Pérez, M. A. Pericàs, A. Vidal-Ferran, Adv. Synth.
Catal. 2008, 350, 1984-1990; b) H. Fernández-Pérez, S. M. A. Donald,
[20] For example, see: C. R. Landis, S. Feldgus, Angew. Chem., Int. Ed.
2000, 39, 2863-2866.
This article is protected by copyright. All rights reserved.